Exagen (XGN) to Release Earnings on Tuesday

Exagen (NASDAQ:XGN) is scheduled to post its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Exagen to post earnings of ($0.30) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Exagen Stock Performance

NASDAQ:XGN opened at $2.85 on Friday. The company has a quick ratio of 4.32, a current ratio of 4.32 and a debt-to-equity ratio of 1.13. The firm has a 50-day moving average price of $2.84 and a 200 day moving average price of $2.33. The firm has a market capitalization of $49.56 million, a PE ratio of -2.94 and a beta of 1.35. Exagen has a 12-month low of $1.30 and a 12-month high of $3.71.

Exagen Company Profile

Exagen Inc develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).